National Cancer Institute; Notice of Closed Meetings, 4276-4277 [07-365]

Download as PDF 4276 Federal Register / Vol. 72, No. 19 / Tuesday, January 30, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Description of Technology: Cystic fibrosis (CF) is a common genetic disease that affects the entire body, producing thick, sticky mucus that clogs the lungs, pancreas, and other organs. It is the most common fatal genetic disease in the United States, and is caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR). Researchers at NIEHS have developed a cell line, CF/T43, which was produced by infection of airway epithelial cells isolated from CF patients with an SV40T retrovirus. CF/T43 cells maintain the abnormal ion transport characteristics of CF while having proliferation capability beyond that of a primary epithelial cell culture. Key features of the CF/T43 cell line include the formation of functional tight junctions, reduced apical membrane chloride conductance, and activation of apical chloride channels by calcium ionophores but not by cAMP-dependent agonists. This cell line may be used for elucidation of the mechanisms of CF, testing candidate complementary genes for correction of the observed CF abnormalities, and for developing and testing therapeutic CF drugs. Applications: Research tool for developing new therapies to treat cystic fibrosis; Research tool for studying the mechanisms of cystic fibrosis. Inventors: Anton M. Jetten (NIEHS). Publication: AM Jetten, JR Yankaskas, MJ Stutts, NJ Willumsen, and RC Boucher. Persistence of abnormal chloride conductance regulation in SV40 T transformed cystic fibrosis airway epithelia. Science 1989 Jun 23;244(4911):1472–1475. Patent Status: U.S. Patent Application No. 07/368,725 filed 21 June 1989, which issued as U.S. Patent No. 5,420,033 on 30 May 1995 (HHS Reference No. E–201–1989/0–US–01). Licensing Status: Available for exclusive or nonexclusive licensing. Licensing Contact: Tara Kirby, Ph.D.; 301/435–4426; tarak@mail.nih.gov. ycherry on PROD1PC64 with NOTICES Epithelial Cell Line Expressing a Cystic Fibrosis Phenotype National Institutes of Health Dated: January 20, 2007. Steven M. Ferguson, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. E7–1379 Filed 1–29–07; 8:45 am] BILLING CODE 4140–01–P VerDate Aug<31>2005 15:36 Jan 29, 2007 Jkt 211001 National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5. U.S.C., as amended. The grant applications and/or contact proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel, R25 Special Emphasis Panel. Date: February 6, 2007. Time: 5 p.m. to 6 p.m. Agenda: To review and evaluate grant applications. Place: Washington Court Hotel, 525 New Jersey Ave, NW., Washington, DC 20001. Contact Person: David E. Maslow, PhD., Chief, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard—Room 8117, Bethesda, MD 20892–7405, (301) 496– 2330. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Cancer Institute Special Emphasis Panel, Arrays for Biomarker. Date: February 13, 2007. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate contract proposals. Place: National Institutes of Health, 6116 Executive Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lalita D. Palekar, PhD, Scientific Review Administrator, Special Review and Resources Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda, MD 20892–7405, (301) 496–7575. Name of Committee: National Cancer Institute Special Emphasis Panel; Multiplex Affinity Capture Technology. Date: February 15, 2007. Time: 12 p.m. to 6 p.m. Agenda: To review and evaluate contract proposals. PO 00000 Frm 00046 Fmt 4703 Sfmt 4703 Place: National Institutes of Health, 6116 Executive Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Lalita D. Palekar, PhD, Scientific Review Administrator, Special Review and Resources Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda, MD 20892–7405, (301) 496–7575. Name of Committee: National Cancer Institute Special Emphasis Panel; Manpower and Training Grants. Date: February 27–28, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria, VA 22314. Contact Person: Lynn M Amende, PhD, Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, 6116 Executive Boulevard Room 8105, Bethesda, MD 20892–8328, 301–451– 4759, amendel@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; Small Grants Program for Cancer Epidemiology and Cancer Prevention Research. Date: March 6–8, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007. Contact Person: Irina Gordienko, PhD, Scientific Review Administrator, Special Review and Logistics Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 703, MS 2829, Bethesda, MD 20892, 301– 594–1566, gordienoiv@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel, AntiCancer Agents. Date: March 15, 2007. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health Events Management, Executive Plaza North Conference Center, 6130 Executive Boulevard, Conference Room D, Rockville, MD 20852, (Telephone Conference Call). Contact Person: Jeannette F Korczak, PhD, Scientific Review Administrator, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 6116 Executive Blvd., Room 8115, Bethesda, MD 20892, 301–496–9767, korczakj@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) E:\FR\FM\30JAN1.SGM 30JAN1 Federal Register / Vol. 72, No. 19 / Tuesday, January 30, 2007 / Notices Dated: January 21, 2007. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–365 Filed 1–29–07; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Nursing Research; Notice of Closed Meeting BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. ycherry on PROD1PC64 with NOTICES Name of Committee: Minority Programs Review Committee, MARC Review Subcommittee A. Date: February 15, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Ave., Bethesda, MD 20814. Contact Person: Mona R. Trempe, PhD, Scientific Review Administrator, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN12, Bethesda, MD 20892, 301–594–3998, trempemo@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: January 21, 2007. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–358 Filed 1–29–07; 8:45 am] BILLING CODE 4140–01–M VerDate Aug<31>2005 15:36 Jan 29, 2007 Jkt 211001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Special Emphasis Panel, Mentored Research Scientist Development Award. Date: March 5, 2007. Time: 7:30 a.m. to 8 a.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Hotel, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: John E. Richters, PhD, Chief, Office of Review, Division of Extramural Activities, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Blvd. Room 715, Bethesda, MD 20817, (301) 594–5971, jrichters@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: January 21, 2007. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–359 Filed 1–29–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of of Nursing Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 4277 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Nursing Research Special Emphasis Panel, RFA–NR–07–002/3: Culturally Appropriate Research to Prevent HIV Transmission. Date: March 14–15, 2007. Time: 8 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Crowne Plaza Hotel, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: John E. Richters, PhD, Chief, Office of Review, Division of Extramural Activities, National Institute of Nursing Research, National Institutes of Health, 6701 Democracy Blvd. Room 715, Bethesda, MD 20817, (301) 594–5971, jrichters@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS) Dated: January 21, 2007. David Clary, Acting Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–360 Filed 1–29–07; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Communication Disorders Review Committee, CDRC. Date: February 15–16, 2007. Time: February 15, 2007, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. E:\FR\FM\30JAN1.SGM 30JAN1

Agencies

[Federal Register Volume 72, Number 19 (Tuesday, January 30, 2007)]
[Notices]
[Pages 4276-4277]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 07-365]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5. 
U.S.C., as amended. The grant applications and/or contact proposals and 
the discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications and/or 
contract proposals, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, R25 Special Emphasis Panel.
    Date: February 6, 2007.
    Time: 5 p.m. to 6 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Washington Court Hotel, 525 New Jersey Ave, NW., 
Washington, DC 20001.
    Contact Person: David E. Maslow, PhD., Chief, Resources and 
Training Review Branch, Division of Extramural Activities, National 
Cancer Institute, National Institutes of Health, 6116 Executive 
Boulevard--Room 8117, Bethesda, MD 20892-7405, (301) 496-2330.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Arrays for Biomarker.
    Date: February 13, 2007.
    Time: 12 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda, 
MD 20892-7405, (301) 496-7575.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Multiplex Affinity Capture Technology.
    Date: February 15, 2007.
    Time: 12 p.m. to 6 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 6116 Executive Boulevard, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Lalita D. Palekar, PhD, Scientific Review 
Administrator, Special Review and Resources Branch, Division of 
Extramural Activities, National Cancer Institute, National 
Institutes of Health, 6116 Executive Boulevard, Room 8105, Bethesda, 
MD 20892-7405, (301) 496-7575.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Manpower and Training Grants.
    Date: February 27-28, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Old Town Alexandria, 1767 King Street, Alexandria, 
VA 22314.
    Contact Person: Lynn M Amende, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, 6116 Executive 
Boulevard Room 8105, Bethesda, MD 20892-8328, 301-451-4759, 
amendel@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; Small Grants Program for Cancer Epidemiology and Cancer 
Prevention Research.
    Date: March 6-8, 2007.
    Time: 8 a.m. to 5 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., 
Washington, DC 20007.
    Contact Person: Irina Gordienko, PhD, Scientific Review 
Administrator, Special Review and Logistics Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Rm. 703, MS 2829, Bethesda, MD 20892, 301-594-1566, 
gordienoiv@mail.nih.gov.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel, Anti-Cancer Agents.
    Date: March 15, 2007.
    Time: 11 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health Events Management, 
Executive Plaza North Conference Center, 6130 Executive Boulevard, 
Conference Room D, Rockville, MD 20852, (Telephone Conference Call).
    Contact Person: Jeannette F Korczak, PhD, Scientific Review 
Administrator, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 6116 
Executive Blvd., Room 8115, Bethesda, MD 20892, 301-496-9767, 
korczakj@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)


[[Page 4277]]


    Dated: January 21, 2007.
David Clary,
Acting Director, Office of Federal Advisory Committee Policy.
[FR Doc. 07-365 Filed 1-29-07; 8:45 am]
BILLING CODE 4140-01-M
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.